Ovid Therapeutics (1OT.F) Q3 2025 Earnings

13AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.19
-0.15
-0.1
-0.05

Details

Expected EPS
-0.13479499593
Actual EPS
-0.0512298
Surprise EPS
0.08
Surprise Percent
+61.99%

Description

Ovid Therapeutics (1OT.F) has reported earnings of -0.0512298 per share for Q3 2025.

0 Comments

Share your thoughts